Advertisement
ALGN vs SAUHY
Which Stock Would AI Choose? Align Technology (ALGN) vs. Straumann Holding (SAUHY) Stock Comparison
Key Takeaways
- ALGN has outperformed SAUHY year-to-date with approximately 22% gains compared to SAUHY's 6%, driven by strong clear aligner demand.
- ALGN approaches Q1 2026 earnings on April 29 with consensus expectations of $1.02 billion in revenue and $2.26 EPS, building on recent beats.
- SAUHY reported full-year 2025 revenue of CHF 2.6 billion, reflecting 8.9% organic growth, amid a softer share price trend in recent weeks.
- ALGN trades at a lower forward P/E ratio around 18 versus SAUHY's approximately 30, suggesting relatively better valuation.
- Both companies operate in the dental sector but differ in focus: ALGN on aligners, SAUHY on implants and biomaterials.
- Recent market activity shows ALGN with more upward momentum, while SAUHY faces downward pressure in pricing.
Introduction
Align Technology (ALGN) and Straumann Holding (SAUHY) represent key players in the dental and orthodontic equipment sector, where innovation in treatments like clear aligners and implants drives growth. This comparison analyzes their recent market performance, business dynamics, and relative positioning amid evolving consumer demand for aesthetic dentistry. Traders seeking short-term momentum or investors eyeing long-term sector exposure may find value in understanding their contrasts, particularly as macroeconomic factors influence healthcare spending and procedural volumes. With both stocks sensitive to global economic shifts, this head-to-head review highlights opportunities in current market conditions.
ALGN Overview and Recent Performance
Align Technology (ALGN), the maker of Invisalign clear aligners and iTero intraoral scanners, specializes in digital orthodontics. In recent market activity, the stock has shown resilience, trading around $190 after fluctuating between $185 and $196 over recent weeks. Year-to-date gains exceed 22%, outpacing broader indices, fueled by sustained demand for non-invasive alignment solutions. The company's Q4 2025 results beat expectations with EPS of $3.29 and revenue growth of 5.3%, boosting sentiment. Upcoming Q1 2026 earnings are anticipated to reflect continued clear aligner shipments and scanner adoption, supporting positive momentum despite broader market volatility.
SAUHY Overview and Recent Performance
Straumann Holding (SAUHY), a Swiss-based leader in dental implants, restorative therapies, orthodontics, and biomaterials, operates globally through its American Depositary Receipts (ADRs). Recent weeks have seen the stock hover around $10.85-$11.74, reflecting a downward trend from earlier highs near $13, with year-to-date returns at about 6%. Full-year 2025 results delivered CHF 2.6 billion in revenue, up 8.9% organically, driven by implant systems and digital solutions. Sentiment has been tempered by currency headwinds and competitive pressures in the implant market, contributing to softer pricing behavior.
Trending AI Robots
Tickeron's Trending AI Robots page curates the top 25 AI-powered trading bots from a library of over 350, selected for their suitability to prevailing market conditions like sector rotations and volatility. These bots employ diverse strategies—ranging from trend-following to pattern recognition—across stocks, ETFs, and crypto, with timeframes from minutes to months. Performance highlights include annualized returns of 15% to 167%, win rates between 48% and 88%, and profit factors up to 11.7, based on virtual trading simulations with robust risk metrics like profit-to-drawdown ratios exceeding 20 in top performers. Popular themes cover semiconductors, aerospace, and leveraged plays. Explore these bots to potentially enhance your trading with data-driven signals tailored to dynamic environments.
Head-to-Head Comparison
Align Technology (ALGN) focuses on a consumer-driven clear aligner model, benefiting from direct-to-consumer trends and high-margin recurring revenues, while Straumann Holding (SAUHY) emphasizes premium implants and biomaterials with stronger B2B exposure to dental practices. Growth drivers diverge: ALGN leverages Invisalign volume amid rising teen and adult adoption, whereas SAUHY pursues organic expansion in emerging markets. Recent momentum favors ALGN's 22% YTD surge over SAUHY's 6%, reflecting superior trend consistency. Risk factors include regulatory scrutiny for ALGN and forex volatility for SAUHY. Valuation metrics highlight ALGN's forward P/E (price-to-earnings ratio) advantage at around 18 versus SAUHY's 30, with a lower PEG (price/earnings-to-growth) ratio. Sector sentiment tilts toward digital orthodontics, positioning ALGN more favorably in current aesthetics-focused demand.
Tickeron AI Verdict
Tickeron's AI models currently lean toward ALGN over SAUHY, citing stronger year-to-date momentum, consistent earnings beats, and upward price trends in recent activity. ALGN's positioning ahead of Q1 results and relative valuation edge suggest higher probability of near-term outperformance, though SAUHY's implant stability offers defensive appeal in downturns. This assessment reflects observable trends rather than guarantees.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer. Disclaimers and Limitations
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALGN is a Hold and SAUHY is a Hold.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALGN’s FA Score shows that 0 FA rating(s) are green whileSAUHY’s FA Score has 0 green FA rating(s).
- ALGN’s FA Score: 0 green, 5 red.
- SAUHY’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALGN’s TA Score shows that 3 TA indicator(s) are bullish while SAUHY’s TA Score has 5 bullish TA indicator(s).
- ALGN’s TA Score: 3 bullish, 7 bearish.
- SAUHY’s TA Score: 5 bullish, 5 bearish.
Price Growth
ALGN (@Pharmaceuticals: Other) experienced а -7.01% price change this week, while SAUHY (@Pharmaceuticals: Other) price change was -4.49% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.97%. For the same industry, the average monthly price growth was -1.36%, and the average quarterly price growth was +21.62%.
Reported Earning Dates
ALGN is expected to report earnings on Jul 29, 2026.
SAUHY is expected to report earnings on Aug 19, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (-1.97% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
| ALGN | SAUHY | ALGN / SAUHY | |
| Capitalization | 11.6B | 17.1B | 68% |
| EBITDA | 877M | 628M | 140% |
| Gain YTD | 3.586 | -6.161 | -58% |
| P/E Ratio | 27.18 | 37.31 | 73% |
| Revenue | 4.1B | 2.61B | 157% |
| Total Cash | 1.06B | N/A | - |
| Total Debt | 116M | N/A | - |
ALGN | SAUHY | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 66 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 77 Overvalued | 35 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 67 | 53 | |
PRICE GROWTH RATING 1..100 | 60 | 62 | |
P/E GROWTH RATING 1..100 | 73 | 56 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
SAUHY's Valuation (35) in the null industry is somewhat better than the same rating for ALGN (77) in the Medical Specialties industry. This means that SAUHY’s stock grew somewhat faster than ALGN’s over the last 12 months.
SAUHY's Profit vs Risk Rating (100) in the null industry is in the same range as ALGN (100) in the Medical Specialties industry. This means that SAUHY’s stock grew similarly to ALGN’s over the last 12 months.
SAUHY's SMR Rating (53) in the null industry is in the same range as ALGN (67) in the Medical Specialties industry. This means that SAUHY’s stock grew similarly to ALGN’s over the last 12 months.
ALGN's Price Growth Rating (60) in the Medical Specialties industry is in the same range as SAUHY (62) in the null industry. This means that ALGN’s stock grew similarly to SAUHY’s over the last 12 months.
SAUHY's P/E Growth Rating (56) in the null industry is in the same range as ALGN (73) in the Medical Specialties industry. This means that SAUHY’s stock grew similarly to ALGN’s over the last 12 months.
| ALGN | SAUHY | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 61% | 1 day ago 63% |
| Stochastic ODDS (%) | 1 day ago 67% | 1 day ago 76% |
| Momentum ODDS (%) | 1 day ago 71% | 1 day ago 67% |
| MACD ODDS (%) | 1 day ago 77% | 1 day ago 63% |
| TrendWeek ODDS (%) | 1 day ago 71% | 1 day ago 70% |
| TrendMonth ODDS (%) | 1 day ago 77% | 1 day ago 72% |
| Advances ODDS (%) | 23 days ago 71% | 9 days ago 69% |
| Declines ODDS (%) | 10 days ago 73% | 3 days ago 72% |
| BollingerBands ODDS (%) | 1 day ago 71% | 1 day ago 73% |
| Aroon ODDS (%) | 1 day ago 75% | 1 day ago 68% |
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OKLS | 19.01 | 1.80 | +10.46% |
| Defiance Daily Target 2X Short OKLO ETF | |||
| UMMA | 36.50 | 0.69 | +1.92% |
| Wahed Dow Jones Islamic World ETF | |||
| FDLO | 69.12 | 0.11 | +0.16% |
| Fidelity Low Volatility Factor ETF | |||
| XISE | 30.40 | 0.02 | +0.07% |
| FT Vest US Eq Buf & Prm IncETF-Sept | |||
| LAYS | 64.18 | N/A | N/A |
| Stkd 100% Nvda & 100% Amd ETF | |||
SAUHY and
Correlation & Price change
A.I.dvisor indicates that over the last year, SAUHY has been loosely correlated with SONVY. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if SAUHY jumps, then SONVY could also see price increases.
| Ticker / NAME | Correlation To SAUHY | 1D Price Change % | ||
|---|---|---|---|---|
| SAUHY | 100% | +0.28% | ||
| SONVY - SAUHY | 49% Loosely correlated | -2.56% | ||
| ALGN - SAUHY | 49% Loosely correlated | -2.44% | ||
| SAUHF - SAUHY | 47% Loosely correlated | +1.33% | ||
| SMMNY - SAUHY | 44% Loosely correlated | -0.07% | ||
| CZMWY - SAUHY | 38% Loosely correlated | -12.16% | ||
More | ||||